4//SEC Filing
Kalergis David G 4
Accession 0001437749-20-001421
CIK 0001053691other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:54 PM ET
Size
5.4 KB
Accession
0001437749-20-001421
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2020-01-02+262,900→ 262,900 totalExercise: $0.46Exp: 2030-01-31→ Common Stock (262,900 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2020.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001663574
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:54 PM ET
- Size
- 5.4 KB